# Lactated Ringer's Versus 5% Human Albumin: Cardiac Surgical Patients

> **NCT02654782** · PHASE2 · TERMINATED · sponsor: **William C. Oliver** · enrollment: 10 (actual)

## Conditions studied

- Hemodynamic Stability

## Interventions

- **DRUG:** Lactated Ringer's
- **DRUG:** 5% Human Albumin

## Key facts

- **NCT ID:** NCT02654782
- **Lead sponsor:** William C. Oliver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2017-10-09
- **Final completion:** 2017-10-09
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Student performing study left Mayo Clinic, no funds to continue study.
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654782, "Lactated Ringer's Versus 5% Human Albumin: Cardiac Surgical Patients". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02654782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*